AMS GreenLight XPS Therapy Laser System: An Advanced Approach to Laser Therapy.
The GreenLight XPS Laser Therapy System represents a significant advancement in the treatment of benign prostatic hyperplasia (BPH), offering a powerful solution that redefines the standard of care for this common condition. With its 180W output and 532nm wavelength laser, the GreenLight XPS is specifically designed to address the symptoms of BPH effectively and efficiently.
At the heart of the GreenLight XPS system is the MoXy liquid-cooled fiber, which enables fast and efficient vaporization of prostatic tissue while maintaining the same safety profile as the current GreenLight HPS technology. This innovative fiber design, combined with the increased power of the XPS/MoXy system, results in a 50% increase in both power and laser beam area. This enhancement allows for a wider tissue vaporization effect without compromising the depth of vaporization and coagulation achieved with the clinically proven HPS and PV systems.
Throughout the procedure, the MoXy liquid-cooled fiber significantly enhances vaporization efficiency, leading to the removal of twice as much tissue over the same lasing time compared to conventional methods. Importantly, the XPS with MoXy technology enables the removal of a wider section of tissue without increasing the depth of tissue removal, ensuring precise treatment while minimizing damage to surrounding areas.
Furthermore, the GreenLight XPS system incorporates Active Cooling Cap technology, which utilizes saline flow to minimize fiber tip devitrification. This innovative approach significantly reduces power degradation throughout the duration of the procedure, ensuring consistent performance and optimal treatment outcomes.
The GreenLight XPS Laser Therapy System incorporates revolutionary proprietary technology that not only enhances treatment efficacy but also significantly improves fiber longevity and reduces cap-related failures. Compared to the HPS fiber, this innovative technology has been shown to decrease cap-related failures by an impressive 90%. Furthermore, the system is equipped with built-in alerts that notify users of conditions such as excessive heat, including the presence of prostatic calculi, ensuring enhanced safety and procedural efficiency.
With the GreenLight XPS, clinicians can confidently treat glands larger than 120 grams using only one fiber, thanks to its advanced capabilities and Active Cooling Cap technology. This technology utilizes saline flow to keep the fiber tip cooled, reducing fiber cap-related failures and minimizing beam devitrification or power degradation, thus extending the life of the fiber. By offering exceptional durability and reliability, the GreenLight XPS enables clinicians to perform procedures with greater confidence and efficiency.
Additionally, the GreenLight XPS introduces TruCoag technology, which utilizes pulsating light to cauterize ruptured vessels and reduce bleeding faster and in more situations compared to traditional methods. This innovative approach not only enhances hemostasis but also provides better control of aberrant bleeders compared to previous GreenLight HPS and PV laser consoles. With TruCoag, clinicians can achieve superior outcomes and minimize complications, further advancing the standard of care for BPH treatment.
